Boston Scientific
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Boston Scientific generated cash of $2,503,000,000, which is more than the previous year. Cash used in financing activities reached the amount of $5,000,000 last year. Net change in cash is therefore -$71,000,000.
Cash Flow
| 2014 | 1.26B | -745M | -150M |
|---|---|---|---|
| 2015 | 600M | -2.18B | 1.32B |
| 2016 | 972M | -887M | -206M |
| 2017 | 1.42B | -1.01B | 110M |
| 2018 | 310M | -1.92B | 1.43B |
| 2019 | 1.83B | -5.04B | 2.97B |
| 2020 | 1.50B | -411M | 293M |
| 2021 | 1.87B | -1.59B | -95M |
| 2022 | 1.52B | -2.01B | -548M |
| 2023 | 2.50B | -2.57B | 5M |
BSX Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 1.12B | 2.16B | 1.99B | 607M | 829M | 1.01B | 487M | 319M | 587M | 217M |
Operating activities | ||||||||||
Net income | 1.59B | 698M | 1.04B | -82M | 4.7B | 1.67B | 104M | 347M | -239M | -119M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 1.19B | 1.13B | 1.09B | 1.12B | 1.01B | 894M | 844M | 815M | 769M | 725M |
Stock-based compensation expense | 233M | 220M | 194M | 170M | 157M | 0 | 127M | 116M | 107M | 103M |
| Deferred income tax benefit | 233M | 220M | 194M | 170M | 157M | 0 | 127M | 116M | 107M | 103M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -238M | -220M | -279M | 335M | -130M | -110M | -30M | -216M | -17M | 53M |
Inventories | -660M | -321M | -346M | -65M | -290M | -83M | -107M | 40M | 3M | -81M |
Accounts payable | 118M | -255M | 408M | 88M | 111M | -710M | 195M | 553M | -20M | 620M |
Cash generated by operating activities | 2.50B | 1.52B | 1.87B | 1.50B | 1.83B | 310M | 1.42B | 972M | 600M | 1.26B |
Investing activities | ||||||||||
Purchases Of Investments | 0 | -24M | 96M | -146M | -348M | -172M | -131M | -132M | -266M | -26M |
Investments In Property Plant And Equipment | -711M | -612M | -554M | -376M | -461M | -316M | -319M | -376M | -247M | -259M |
Acquisitions Net | -1.81B | -1.53B | -1.43B | 12M | -4.29B | -1.44B | -560M | -408M | -1.73B | -474M |
Cash generated by investing activities | -2.57B | -2.01B | -1.59B | -411M | -5.04B | -1.92B | -1.01B | -887M | -2.18B | -745M |
Financing activities | ||||||||||
Common Stock Issued | 182M | 0 | 110M | 975M | 123M | 101M | 85M | 111M | 114M | 0 |
Payments for dividends | -28M | -55M | -55M | -28M | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 182M | 136M | 0 | -535M | 0 | 0 | 0 | 0 | 0 | -125M |
Repayments of term debt | -4M | -165M | 0 | -6.84B | 2.79B | -1.17B | 123M | -820M | 1.38B | 0 |
Cash used in financing activities | 5M | -548M | -95M | 293M | 2.97B | 1.43B | 110M | -206M | 1.32B | -150M |
Net Change In Cash | -71M | -1.04B | 173M | 1.38B | -222M | -188M | 530M | -123M | -268M | 370M |
Cash at end of period | 1.05B | 1.12B | 2.16B | 1.99B | 607M | 829M | 1.01B | 196M | 319M | 587M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |